{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:58:03Z","timestamp":1770508683927,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"5P2","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":615,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>Noncompliance with treatment protocols produces an increased burden on the health care system. Reports show that 23% of annual admissions to nursing homes in the United States (380,000 patients) are due to noncompliance, resulting in overall costs of over $31 billion. More than 10% of all patients (3.5 million) are hospitalized each year due to complications related to noncompliance, with over $15 billion spent. In addition, nearly half of the 2 billion prescriptions filled each year are not taken correctly. Patients with cirrhosis and hepatic encephalopathy who are prescribed lactulose experience a greater frequency of adverse effects, require more hospitalizations, and suffer more disease recurrence than those prescribed rifaximin.<\/jats:p>","DOI":"10.1592\/phco.30.pt2.22s","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T07:22:33Z","timestamp":1272007353000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Factors Affecting Compliance and Persistence with Treatment for Hepatic Encephalopathy"],"prefix":"10.1002","volume":"30","author":[{"given":"Guy","family":"Neff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2.6.785"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-6342.2006.03215.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80144-5"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0739"},{"key":"e_1_2_1_7_2","first-page":"20","article-title":"Drugs as a reason for nursing home admissions","volume":"10","author":"Standberg LR.","year":"1984","journal-title":"J Am Health Care Assoc"},{"key":"e_1_2_1_8_2","unstructured":"Schering Laboratories.Schering report IX: the forgetful patient: the high cost of improper patient compliance. Available fromhttp:www.cadexwatch.comcompliance.htmlAccessedJanuary 14 2010."},{"key":"e_1_2_1_9_2","unstructured":"Oregon Department of Human Resources.A study of long\u2010term care in Oregon with emphasis on the elderly.1981. Available fromhttp:www.unitdose.orgbibliography.htm. Accessed January 14 2010."},{"key":"e_1_2_1_10_2","unstructured":"National Council for Patient Information and Education.Educate before you medicate. Available fromhttp:www. talkaboutrx.orgAccessedJanuary 14 2010."},{"key":"e_1_2_1_11_2","unstructured":"HayesRB.NCPIE prescription month October 1989. Available fromwww.cadexwatch.comcompliance.htmlAccessedJanuary 14 2010."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03425.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:MEBR.0000043986.70972.3b"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(09)60179-3"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9442-4"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(09)60095-7"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(09)60209-9"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(88)80515-4"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840070306"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.30.pt2.22S","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.30.pt2.22S","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:47:35Z","timestamp":1761040055000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.30.pt2.22S"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":18,"journal-issue":{"issue":"5P2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1592\/phco.30.pt2.22S"],"URL":"https:\/\/doi.org\/10.1592\/phco.30.pt2.22s","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}